The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Programming gene and engineered-cell therapies with synthetic biology
Open accessAbstract
Toward programmed therapeutics: Advances in synthetic biology are enabling the development of new gene and cell therapies. Kitada et al. review recent successes in areas such as cancer immunotherapy and stem cell therapy, point out the limitations of current approaches, and describe prospects for using synthetic biology to overcome these challenges. Broader adoption of these therapies requires precise, context-specific control over cellular behavior. Gene circuits can be built to give sophisticated control over cellular behaviors so that therapeutic functions can, for example, be programmed to activate in response to disease biomarkers. Science , this issue p. eaad1067
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage
Komor, A. C., Kim, Y. B., Packer, M. S., Zuris, J. A., & Liu, D. R. (2016) · Nature · doi:10.1038/nature17946 · Cited by 5,437
A synthetic oscillatory network of transcriptional regulators
Elowitz, M. B., & Leibler, S. (2000) · Nature · doi:10.1038/35002125 · Cited by 4,630
Construction of a genetic toggle switch in Escherichia coli
Gardner, T. S., Cantor, C. R., & Collins, J. J. (2000) · Nature · doi:10.1038/35002131 · Cited by 4,268
Programmable base editing of A•T to G•C in genomic DNA without DNA cleavage
Gaudelli, N. M., Komor, A. C., Rees, H. A., Packer, M. S., Badran, A. H., Bryson, D. I., & Liu, D. R. (2017) · Nature · doi:10.1038/nature24644 · Cited by 4,184
Nucleic acid detection with CRISPR-Cas13a/C2c2
Gootenberg, J. S., Abudayyeh, O. O., Lee, J. W., Essletzbichler, P., Dy, A. J., Joung, J., Verdine, V., Donghia, N., Daringer, N. M., Freije, C. A., et al. (2017) · Science · doi:10.1126/science.aam9321 · Cited by 3,844
From molecular to modular cell biology.
Hartwell, L. H., Hopfield, J. J., Leibler, S., & Murray, A. W. (1999) · Nature · doi:10.1038/35011540 · Cited by 3,632
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Non-viral vectors for gene-based therapy
Yin, H., Kanasty, R. L., Eltoukhy, A. A., Vegas, A. J., Dorkin, J. R., & Anderson, D. G. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3763 · Cited by 3,123
Boehncke, W.-H., & Schön, M. P. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61909-7 · Cited by 2,542
mRNA-based therapeutics--developing a new class of drugs
Sahin, U., Karikó, K., & Türeci, Ö. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4278 · Cited by 2,474
C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
Abudayyeh, O. O., Gootenberg, J. S., Konermann, S., Joung, J., Slaymaker, I. M., Cox, D. B. T., Shmakov, S., Makarova, K. S., Semenova, E., Minakhin, L., et al. (2016) · Science · doi:10.1126/science.aaf5573 · Cited by 2,336
RNA targeting with CRISPR–Cas13
Abudayyeh, O. O., Gootenberg, J. S., Essletzbichler, P., Han, S., Joung, J., Belanto, J. J., Verdine, V., Cox, D. B. T., Kellner, M. J., Regev, A., et al. (2017) · Nature · doi:10.1038/nature24049 · Cited by 2,093
Adenovirus-Associated Virus Vector–Mediated Gene Transfer in Hemophilia B
Nathwani, A. C., Tuddenham, E. G. D., Rangarajan, S., Rosales, C., McIntosh, J., Linch, D. C., Chowdary, P., Riddell, A., Pie, A. J., Harrington, C., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1108046 · Cited by 1,864
Cox, D. B. T., Gootenberg, J. S., Abudayyeh, O. O., Franklin, B., Kellner, M. J., Joung, J., & Zhang, F. (2017) · Science · doi:10.1126/science.aaq0180 · Cited by 1,834
Emergent Properties of Networks of Biological Signaling Pathways
Bhalla, U. S., & Iyengar, R. (1999) · Science · doi:10.1126/science.283.5400.381 · Cited by 1,686
T Lymphocyte-Directed Gene Therapy for ADA − SCID: Initial Trial Results After 4 Years
Blaese, R. M., Culver, K. W., Miller, A. D., Carter, C. S., Fleisher, T., Clerici, M., Shearer, G., Chang, L., Chiang, Y., Tolstoshev, P., et al. (1995) · Science · doi:10.1126/science.270.5235.475 · Cited by 1,550
Kochenderfer, J. N., Dudley, M. E., Feldman, S. A., Wilson, W. H., Spaner, D. E., Maric, I., Stetler-Stevenson, M., Phan, G. Q., Hughes, M. S., Sherry, R. M., et al. (2012) · Blood · doi:10.1182/blood-2011-10-384388 · Cited by 1,440
Gene Editing of CCR5 in Autologous CD4 T Cells of Persons Infected with HIV
Tebas, P., Stein, D., Tang, W. W., Frank, I., Wang, S. Q., Lee, G., Spratt, S. K., Surosky, R. T., Giedlin, M. A., Nichol, G., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1300662 · Cited by 1,357
GAL4-VP16 is an unusually potent transcriptional activator
Sadowski, I., Ma, J., Triezenberg, S., & Ptashne, M. (1988) · Nature · doi:10.1038/335563a0 · Cited by 1,333
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Cavazzana-Calvo, M., Payen, E., Negre, O., Wang, G., Hehir, K., Fusil, F., Down, J., Denaro, M., Brady, T., Westerman, K., et al. (2010) · Nature · doi:10.1038/nature09328 · Cited by 1,276
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
Nathwani, A. C., Reiss, U. M., Tuddenham, E. G. D., Rosales, C., Chowdary, P., McIntosh, J., Della Peruta, M., Lheriteau, E., Patel, N., Raj, D., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1407309 · Cited by 1,273
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Gene therapy returns to centre stage
Naldini, L. (2015) · Nature · doi:10.1038/nature15818 · Cited by 1,184 · cited 3×
“Although AAV has been used in several recent gene therapy clinical trials (3), the nucleic acid packaging capacity of AAV is only approximately 5 kb (89), which is too small for many of the synthetic gene circuits described above (although AAV codelivery is being investigated).”
BackgroundMethodInfluentialIn vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy
Nelson, C. E., Hakim, C. H., Ousterout, D. G., Thakore, P. I., Moreb, E. A., Rivera, R. M. C., Madhavan, S., Pan, X., Ran, F. A., Yan, W. X., et al. (2016) · Science · doi:10.1126/science.aad5143 · Cited by 1,144
The Principles of Engineering Immune Cells to Treat Cancer
Lim, W. A., & June, C. H. (2017) · Cell · doi:10.1016/j.cell.2017.01.016 · Cited by 1,080
In vivo gene editing in dystrophic mouse muscle and muscle stem cells
Tabebordbar, M., Zhu, K., Cheng, J. K. W., Chew, W. L., Widrick, J. J., Yan, W. X., Maesner, C., Wu, E. Y., Xiao, R., Ran, F. A., et al. (2016) · Science · doi:10.1126/science.aad5177 · Cited by 1,046
Genetic circuit design automation
Nielsen, A. A. K., Der, B. S., Shin, J., Vaidyanathan, P., Paralanov, V., Strychalski, E. A., Ross, D., Densmore, D., & Voigt, C. A. (2016) · Science · doi:10.1126/science.aac7341 · Cited by 1,020
Finkel, R. S., Chiriboga, C. A., Vajsar, J., Day, J. W., Montes, J., De Vivo, D. C., Yamashita, M., Rigo, F., Hung, G., Schneider, E., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31408-8 · Cited by 1,019
Engineering Customized Cell Sensing and Response Behaviors Using Synthetic Notch Receptors
Morsut, L., Roybal, K. T., Xiong, X., Gordley, R. M., Coyle, S. M., Thomson, M., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.01.012 · Cited by 1,000
Precision Tumor Recognition by T Cells With Combinatorial Antigen-Sensing Circuits
Roybal, K. T., Rupp, L. J., Morsut, L., Walker, W. J., McNally, K. A., Park, J. S., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.01.011 · Cited by 1,000
Long, C., Amoasii, L., Mireault, A. A., McAnally, J. R., Li, H., Sanchez-Ortiz, E., Bhattacharyya, S., Shelton, J. M., Bassel-Duby, R., & Olson, E. N. (2016) · Science · doi:10.1126/science.aad5725 · Cited by 937
Principles of genetic circuit design
Brophy, J. A. N., & Voigt, C. A. (2014) · Nature Methods · doi:10.1038/nmeth.2926 · Cited by 931
Molecular remission of infant B-ALL after infusion of universal TALEN gene-edited CAR T cells
Qasim, W., Zhan, H., Samarasinghe, S., Adams, S., Amrolia, P., Stafford, S., Butler, K., Rivat, C., Wright, G., Somana, K., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aaj2013 · Cited by 902
Banaszynski, L. A., Chen, L.-C., Maynard-Smith, L. A., Ooi, A. G. L., & Wandless, T. J. (2006) · Cell · doi:10.1016/j.cell.2006.07.025 · Cited by 902
Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial
Menter, A., Tyring, S. K., Gordon, K., Kimball, A. B., Leonardi, C. L., Langley, R. G., Strober, B. E., Kaul, M., Gu, Y., Okun, M., et al. (2008) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2007.09.010 · Cited by 889
Multi-Input RNAi-Based Logic Circuit for Identification of Specific Cancer Cells
Xie, Z., Wroblewska, L., Prochazka, L., Weiss, R., & Benenson, Y. (2011) · Science · doi:10.1126/science.1205527 · Cited by 737
Self-citationEngineering T Cells with Customized Therapeutic Response Programs Using Synthetic Notch Receptors
Roybal, K. T., Williams, J. Z., Morsut, L., Rupp, L. J., Kolinko, I., Choe, J. H., Walker, W. J., McNally, K. A., & Lim, W. A. (2016) · Cell · doi:10.1016/j.cell.2016.09.011 · Cited by 721
Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription
Zhang, F., Cong, L., Lodato, S., Kosuri, S., Church, G. M., & Arlotta, P. (2011) · Nature Biotechnology · doi:10.1038/nbt.1775 · Cited by 712
Remote control of therapeutic T cells through a small molecule–gated chimeric receptor
Wu, C.-Y., Roybal, K. T., Puchner, E. M., Onuffer, J., & Lim, W. A. (2015) · Science · doi:10.1126/science.aab4077 · Cited by 687
Programmable RNA recognition and cleavage by CRISPR/Cas9
O’Connell, M. R., Oakes, B. L., Sternberg, S. H., East-Seletsky, A., Kaplan, M., & Doudna, J. A. (2014) · Nature · doi:10.1038/nature13769 · Cited by 632
Maier, M. A., Jayaraman, M., Matsuda, S., Liu, J., Barros, S., Querbes, W., Tam, Y. K., Ansell, S. M., Kumar, V., Qin, J., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2013.124 · Cited by 625
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583
Smargon, A. A., Cox, D. B. T., Pyzocha, N. K., Zheng, K., Slaymaker, I. M., Gootenberg, J. S., Abudayyeh, O. A., Essletzbichler, P., Shmakov, S., Makarova, K. S., et al. (2017) · Molecular Cell · doi:10.1016/j.molcel.2016.12.023 · Cited by 575
Pan, C., Kumar, C., Bohl, S., Klingmueller, U., & Mann, M. (2009) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800258-mcp200 · Cited by 561 · cited 1×
“For instance, differences in intracellular biomolecule amounts between cell lines and primary cells (81) could be debilitating for synthetic gene circuits whose proper function depends sensitively on the concentrations of their modules’ inputs.”
BackgroundTargeted DNA demethylation in vivo using dCas9–peptide repeat and scFv–TET1 catalytic domain fusions
Morita, S., Noguchi, H., Horii, T., Nakabayashi, K., Kimura, M., Okamura, K., Sakai, A., Nakashima, H., Hata, K., Nakashima, K., et al. (2016) · Nature Biotechnology · doi:10.1038/nbt.3658 · Cited by 502
Interleukin-4 therapy of psoriasis induces Th2 responses and improves human autoimmune disease
Ghoreschi, K., Thomas, P., Breit, S., Dugas, M., Mailhammer, R., van Eden, W., van der Zee, R., Biedermann, T., Prinz, J., Mack, M., et al. (2003) · Nature Medicine · doi:10.1038/nm804 · Cited by 453
Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance
Maldonado, R. A., LaMothe, R. A., Ferrari, J. D., Zhang, A.-H., Rossi, R. J., Kolte, P. N., Griset, A. P., O’Neil, C., Altreuter, D. H., Browning, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1408686111 · Cited by 441
Synthetic Biology Moving into the Clinic
Ruder, W. C., Lu, T., & Collins, J. J. (2011) · Science · doi:10.1126/science.1206843 · Cited by 412
Mullokandov, G., Baccarini, A., Ruzo, A., Jayaprakash, A. D., Tung, N., Israelow, B., Evans, M. J., Sachidanandam, R., & Brown, B. D. (2012) · Nature Methods · doi:10.1038/nmeth.2078 · Cited by 394
A CRISPR-based approach for targeted DNA demethylation
Xu, X., Tao, Y., Gao, X., Zhang, L., Li, X., Zou, W., Ruan, K., Wang, F., Xu, G.-L., & Hu, R. (2016) · Cell Discovery · doi:10.1038/celldisc.2016.9 · Cited by 378
Synthetic Biology and Personalized Medicine
Jain, K. K. (2013) · Medical Principles and Practice · doi:10.1159/000341794 · Cited by 376
Traxler, E. A., Yao, Y., Wang, Y.-D., Woodard, K. J., Kurita, R., Nakamura, Y., Hughes, J. R., Hardison, R. C., Blobel, G. A., Li, C., et al. (2016) · Nature Medicine · doi:10.1038/nm.4170 · Cited by 366 · cited 2×
“For example, targetedDNA cleavage and subsequent repair of gene regulatory elements may one day treat b-hemoglobinopathies (15, 16).”
BackgroundProspects for gene-engineered T cell immunotherapy for solid cancers
Klebanoff, C. A., Rosenberg, S. A., & Restifo, N. P. (2016) · Nature Medicine · doi:10.1038/nm.4015 · Cited by 365
Cas9 gRNA engineering for genome editing, activation and repression
Kiani, S., Chavez, A., Tuttle, M., Hall, R. N., Chari, R., Ter-Ovanesyan, D., Qian, J., Pruitt, B. W., Beal, J., Vora, S., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3580 · Cited by 334
Self-citationDirected differentiation of cholangiocytes from human pluripotent stem cells
Ogawa, M., Ogawa, S., Bear, C. E., Ahmadi, S., Chin, S., Li, B., Grompe, M., Keller, G., Kamath, B. M., & Ghanekar, A. (2015) · Nature Biotechnology · doi:10.1038/nbt.3294 · Cited by 317
RNA Targeting by the Type III-A CRISPR-Cas Csm Complex of Thermus thermophilus
Staals, R. H. J., Zhu, Y., Taylor, D. W., Kornfeld, J. E., Sharma, K., Barendregt, A., Koehorst, J. J., Vlot, M., Neupane, N., Varossieau, K., et al. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.10.005 · Cited by 282
Self-sufficient control of urate homeostasis in mice by a synthetic circuit
Kemmer, C., Gitzinger, M., Daoud-El Baba, M., Djonov, V., Stelling, J., & Fussenegger, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1617 · Cited by 281
PUF proteins: repression, activation and mRNA localization
Quenault, T., Lithgow, T., & Traven, A. (2011) · Trends in Cell Biology · doi:10.1016/j.tcb.2010.09.013 · Cited by 277
Programmable RNA Shredding by the Type III-A CRISPR-Cas System of Streptococcus thermophilus
Tamulaitis, G., Kazlauskiene, M., Manakova, E., Venclovas, Č., Nwokeoji, A. O., Dickman, M. J., Horvath, P., & Siksnys, V. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.09.027 · Cited by 275
Foundations for the design and implementation of synthetic genetic circuits
Slusarczyk, A. L., Lin, A., & Weiss, R. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3227 · Cited by 267
Self-citationAiuti, A., Roncarolo, M. G., & Naldini, L. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201707573 · Cited by 264
Genetic control of mammalian T-cell proliferation with synthetic RNA regulatory systems
Chen, Y. Y., Jensen, M. C., & Smolke, C. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001721107 · Cited by 263
Continuous genetic recording with self-targeting CRISPR-Cas in human cells
Perli, S. D., Cui, C. H., & Lu, T. K. (2016) · Science · doi:10.1126/science.aag0511 · Cited by 238
Tunable and reversible drug control of protein production via a self-excising degron
Chung, H. K., Jacobs, C. L., Huo, Y., Yang, J., Krumm, S. A., Plemper, R. K., Tsien, R. Y., & Lin, M. Z. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1869 · Cited by 233
β-cell–mimetic designer cells provide closed-loop glycemic control
Xie, M., Ye, H., Wang, H., Charpin-El Hamri, G., Lormeau, C., Saxena, P., Stelling, J., & Fussenegger, M. (2016) · Science · doi:10.1126/science.aaf4006 · Cited by 224
Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery
Wroblewska, L., Kitada, T., Endo, K., Siciliano, V., Stillo, B., Saito, H., & Weiss, R. (2015) · Nature Biotechnology · doi:10.1038/nbt.3301 · Cited by 222
Self-citationSmall-molecule displacement of a cryptic degron causes conditional protein degradation
Bonger, K. M., Chen, L.-C., Liu, C. W., & Wandless, T. J. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.598 · Cited by 206
Improving the efficacy and safety of biologic drugs with tolerogenic nanoparticles
Kishimoto, T. K., Ferrari, J. D., LaMothe, R. A., Kolte, P. N., Griset, A. P., O'Neil, C., Chan, V., Browning, E., Chalishazar, A., Kuhlman, W., et al. (2016) · Nature Nanotechnology · doi:10.1038/nnano.2016.135 · Cited by 201
The roles of RNA processing in translating genotype to phenotype
Manning, K. S., & Cooper, T. A. (2017) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.139 · Cited by 201
Ye, L., Wang, J., Tan, Y., Beyer, A. I., Xie, F., Muench, M. O., & Kan, Y. W. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1612075113 · Cited by 190
Synthetic translational regulation by an L7Ae–kink-turn RNP switch
Saito, H., Kobayashi, T., Hara, T., Fujita, Y., Hayashi, K., Furushima, R., & Inoue, T. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.273 · Cited by 167
An overview of FDA-approved biologics medicines
Kinch, M. S. (2015) · Drug Discovery Today · doi:10.1016/j.drudis.2014.09.003 · Cited by 164
Conditional transgenic technologies
Ryding, A., Sharp, M., & Mullins, J. (2001) · Journal of Endocrinology · doi:10.1677/joe.0.1710001 · Cited by 160
Chemical control of protein stability and function in living mice
Banaszynski, L. A., Sellmyer, M. A., Contag, C. H., Wandless, T. J., & Thorne, S. H. (2008) · Nature Medicine · doi:10.1038/nm.1754 · Cited by 155
A closed-loop synthetic gene circuit for the treatment of diet-induced obesity in mice
Roessger, K., Hamri, G. C., & Fussenegger, M. (2013) · Nature Communications · doi:10.1038/ncomms3825 · Cited by 151
Interleukin 10 Treatment of Psoriasis
Asadullah, K., Döcke, W. D., Ebeling, M., Friedrich, M., Belbe, G., Audring, H., Volk, H., & Sterry, W. (1999) · Archives of Dermatology · doi:10.1001/archderm.135.2.187 · Cited by 151
Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis
Schukur, L., Geering, B., Hamri, G. C., & Fussenegger, M. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac4964 · Cited by 149
Saxena, P., Heng, B. C., Bai, P., Folcher, M., Zulewski, H., & Fussenegger, M. (2016) · Nature Communications · doi:10.1038/ncomms11247 · Cited by 136
Modularity, context-dependence, and insulation in engineered biological circuits
Vecchio, D. D. (2014) · Trends in biotechnology · doi:10.1016/j.tibtech.2014.11.009 · Cited by 124
Self-adjusting synthetic gene circuit for correcting insulin resistance
Ye, H., Xie, M., Xue, S., Hamri, G. C., Yin, J., Zulewski, H., & Fussenegger, M. (2016) · Nature Biomedical Engineering · doi:10.1038/s41551-016-0005 · Cited by 110
A Synthetic Multifunctional Mammalian pH Sensor and CO2 Transgene-Control Device
Ausländer, D., Ausländer, S., Hamri, G. C., Sedlmayer, F., Müller, M., Frey, O., Hierlemann, A. R., Stelling, J., & Fussenegger, M. (2014) · Molecular Cell · doi:10.1016/j.molcel.2014.06.007 · Cited by 109
Mazzacurati, L., Marzulli, M., Reinhart, B., Miyagawa, Y., Uchida, H., Goins, W. F., Li, A., Kaur, B., Caligiuri, M. A., Cripe, T. P., et al. (2014) · Molecular Therapy · doi:10.1038/mt.2014.177 · Cited by 101
Aronne, L. J., Halseth, A. E., Burns, C. M., Miller, S., & Shen, L. Z. (2010) · Obesity · doi:10.1038/oby.2009.478 · Cited by 100
Modular construction of mammalian gene circuits using TALE transcriptional repressors
Li, Y., Jiang, Y., Chen, H., Liao, W., Li, Z., Weiss, R., & Xie, Z. (2015) · Nature Chemical Biology · doi:10.1038/nchembio.1736 · Cited by 88
Self-citationComputational design approaches and tools for synthetic biology
MacDonald, J. T., Barnes, C. P., Kitney, R. I., Freemont, P. S., & Stan, G.-B. V. (2011) · Integrative Biology · doi:10.1039/c0ib00077a · Cited by 87
Targeted HIV-1 Latency Reversal Using CRISPR/Cas9-Derived Transcriptional Activator Systems
Bialek, J. K., Dunay, G. A., Voges, M., Schäfer, C., Spohn, M., Stucka, R., Hauber, J., & Lange, U. C. (2016) · PLoS ONE · doi:10.1371/journal.pone.0158294 · Cited by 85
Reward-based hypertension control by a synthetic brain–dopamine interface
Roessger, K., Hamri, G. C., & Fussenegger, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1312414110 · Cited by 81
Saxena, P., Hamri, G. C., Folcher, M., Zulewski, H., & Fussenegger, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1514383113 · Cited by 76
Accurate Predictions of Genetic Circuit Behavior from Part Characterization and Modular Composition
Davidsohn, N., Beal, J., Kiani, S., Adler, A., Yaman, F., Li, Y., Xie, Z., & Weiss, R. (2014) · ACS Synthetic Biology · doi:10.1021/sb500263b · Cited by 70
Self-citationA synthetic biology-based device prevents liver injury in mice
Bai, P., Ye, H., Xie, M., Saxena, P., Zulewski, H., Hamri, G. C., Djonov, V., & Fussenegger, M. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.03.020 · Cited by 69
The potential for manipulating RNA with pentatricopeptide repeat proteins
Yagi, Y., Nakamura, T., & Small, I. (2013) · The Plant Journal · doi:10.1111/tpj.12377 · Cited by 66
Stem cells to treat muscular dystrophies – Where are we?
Meng, J., Muntoni, F., & Morgan, J. E. (2010) · Neuromuscular Disorders · doi:10.1016/j.nmd.2010.10.004 · Cited by 62
Gene Therapy for “Bubble Boy” Disease
Hoggatt, J. (2016) · Cell · doi:10.1016/j.cell.2016.06.049 · Cited by 50
Nizzardo, M., Simone, C., Dametti, S., Salani, S., Ulzi, G., Pagliarani, S., Rizzo, F., Frattini, E., Pagani, F., Bresolin, N., et al. (2015) · Scientific Reports · doi:10.1038/srep11746 · Cited by 44
Digital switching in a biosensor circuit via programmable timing of gene availability
Lapique, N., & Benenson, Y. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1680 · Cited by 44
Epstein, A. L. (2009) · Gene Therapy · doi:10.1038/gt.2009.42 · Cited by 36
Kloks, C. P. A. M., Berger, C., Cortez, P., Dean, Y. D., Heinrich, J. N., Jensen, L. B., Koppenburg, V., Kostense, S., Kramer, D., Spindeldreher, S., et al. (2015) · Journal of Immunological Methods · doi:10.1016/j.jim.2015.01.003 · Cited by 35
Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders
Heng, B. C., Aubel, D., & Fussenegger, M. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.01.010 · Cited by 24
Epic $12 billion deal and FDA's approval raise CAR-T to new heights
Dolgin, E. (2017) · Nature Biotechnology · doi:10.1038/nbt1017-891 · Cited by 13
Cited by
Metabolic modulation of tumours with engineered bacteria for immunotherapy
Canale, F. P., Basso, C., Antonini, G., Perotti, M., Li, N., Sokolovska, A., Neumann, J., James, M. J., Geiger, S., Jin, W., et al. (2021) · Nature · doi:10.1038/s41586-021-04003-2 · Cited by 619
Immunotherapy with engineered bacteria by targeting the STING pathway for anti-tumor immunity
Leventhal, D. S., Sokolovska, A., Li, N., Plescia, C., Kolodziej, S. A., Gallant, C. W., Christmas, R., Gao, J.-R., James, M. J., Abin-Fuentes, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-16602-0 · Cited by 458
Engineering the next generation of cell-based therapeutics
Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M., & Veiseh, O. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-022-00476-6 · Cited by 439
Takebe, T., & Wells, J. M. (2019) · Science · doi:10.1126/science.aaw7567 · Cited by 417
Microbiome Engineering: Synthetic Biology of Plant-Associated Microbiomes in Sustainable Agriculture
Ke, J., Wang, B., & Yoshikuni, Y. (2021) · Trends in Biotechnology · doi:10.1016/j.tibtech.2020.07.008 · Cited by 406
Metadata
- Authors
- Kitada, T., DiAndreth, B., Teague, B., & Weiss, R.
- Venue
- Science
- Published
- 2018-02-09
- Volume
- 359
- Issue
- 6376
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2786631874
- Cited by
- 281
- References
- 99
- FWCI
- 7.93
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.